Kingswood Wealth Advisors LLC Invests $137,000 in Science 37 Holdings, Inc. (NASDAQ:SNCE)

Kingswood Wealth Advisors LLC acquired a new stake in shares of Science 37 Holdings, Inc. (NASDAQ:SNCE) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 643,500 shares of the company’s stock, valued at approximately $137,000.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. grew its holdings in Science 37 by 34.2% during the 1st quarter. BlackRock Inc. now owns 4,639,007 shares of the company’s stock valued at $1,306,000 after buying an additional 1,181,010 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Science 37 by 475.9% in the first quarter. Russell Investments Group Ltd. now owns 3,658,794 shares of the company’s stock valued at $1,030,000 after purchasing an additional 3,023,449 shares in the last quarter. Vanguard Group Inc. increased its position in Science 37 by 6.9% in the third quarter. Vanguard Group Inc. now owns 3,221,621 shares of the company’s stock worth $5,187,000 after purchasing an additional 207,174 shares during the last quarter. Citadel Advisors LLC increased its position in Science 37 by 24.7% in the second quarter. Citadel Advisors LLC now owns 1,781,312 shares of the company’s stock worth $3,581,000 after purchasing an additional 353,156 shares during the last quarter. Finally, Alyeska Investment Group L.P. lifted its position in Science 37 by 20.5% during the first quarter. Alyeska Investment Group L.P. now owns 1,766,384 shares of the company’s stock valued at $497,000 after purchasing an additional 300,000 shares during the last quarter. 40.67% of the stock is owned by institutional investors.

Science 37 Stock Up 2.3 %

Shares of NASDAQ:SNCE opened at $0.27 on Thursday. The firm has a fifty day simple moving average of $0.36 and a two-hundred day simple moving average of $0.30. The stock has a market capitalization of $32.24 million, a P/E ratio of -0.25 and a beta of 0.76. Science 37 Holdings, Inc. has a 52 week low of $0.19 and a 52 week high of $0.87.

Science 37 Company Profile

Science 37 Holdings, Inc engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.